Skip to Main Content

Skip Nav Destination

Article navigation

Research Watch| January 12 2022

Ibrutinib Treatment in Early Stage CLL Prolongs Time to Active Disease

Author & Article Information

Online ISSN: 2159-8290

Print ISSN: 2159-8274

©2021 American Association for Cancer Research.

2021

American Association for Cancer Research.

Cancer Discov (2022) 12 (1): OF10.

https://doi.org/10.1158/2159-8290.CD-RW2021-166

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.